Aurinia pharmaceuticals to host conference call to discuss aur200 phase 1 study results on june 30, 2025

Rockville, md. & edmonton, alberta--(business wire)--aurinia pharmaceuticals to host conference call to discuss aur200 phase 1 study results on june 30, 2025.

AUR Ratings Summary

AUR Quant Ranking